Contineum Therapeutics (CTNM) Shares Outstanding (Weighted Average) (2023 - 2025)
Historic Shares Outstanding (Weighted Average) for Contineum Therapeutics (CTNM) over the last 3 years, with Q3 2025 value amounting to $28.1 million.
Historic Shares Outstanding (Weighted Average) for Contineum Therapeutics (CTNM) over the last 3 years, with Q3 2025 value amounting to $28.1 million.